Burlington, Massachusetts, March 18, 2019 — MilliporeSigma today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems. The Milli-Q® Connect online service portal provides digital access to water and system data, allowing users to monitor lab performance remotely and securely.
“Scientists have come to expect the same instant connectivity in their lab as they experience in their personal lives,” said Jean-Charles Wirth, head of Applied Solutions at MilliporeSigma. “This Internet of Things technology gives our customers accessibility to view real-time system information, customized notifications and rapid online diagnostics, whether they are at the lab or at home.”
The Milli-Q® Connect system turns passive data into active, actionable information that is available remotely at any time and from anywhere. This provides a savings opportunity by streamlining the production of quality reports, which can be produced in minutes.
Other benefits include:
MilliporeSigma service personnel have highlighted the value and convenience of the remote diagnostics and assistance feature of Milli-Q® Connect.
“We received a customer call from a remote hospital reporting an issue with their auto-analyzers, which was possibly due to the water quality,” said Ricardo Rodriguez, field service engineer at MilliporeSigma. “Using Milli-Q® Connect, I connected to their system and, by phone, was able to provide the customer with precise guidance on how to rectify the issue. Doing this by phone provided a significant time savings both to our business and to our customer.”
For more than 50 years, Milli-Q® ultrapure water has been used by researchers and scientists worldwide.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
To continue reading please sign in or create an account.Don't Have An Account?